Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v5-FR
Language French French
Date Updated 2022-09-01 2022-02-17
Drug Identification Number 00030767 00030767
Brand name DEPO-MEDROL 80 MG/ML DEPO-MEDROL 80 MG/ML
Common or Proper name DEPO-MEDROL 80 MG/ML DEPO-MEDROL 80 MG/ML
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE
Strength(s) 80MG 80MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 5 x 1mL vial 5 x 1mL vial
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-20 2022-01-20
Estimated end date 2022-05-27
Actual end date 2022-08-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Inventory is on preventative allocation.
Health Canada comments